Approval · Notice of Compliance 21040 · 2018
ONSIOR: Notice of Compliance 21040
Issued June 29, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21040
- Date
- June 29, 2018
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONSIOR | 02375834 | Marketed |
Medicinal ingredients
- ROBENACOXIB 6 MG per TAB